CN104474347A - Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule - Google Patents
Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule Download PDFInfo
- Publication number
- CN104474347A CN104474347A CN201410773466.5A CN201410773466A CN104474347A CN 104474347 A CN104474347 A CN 104474347A CN 201410773466 A CN201410773466 A CN 201410773466A CN 104474347 A CN104474347 A CN 104474347A
- Authority
- CN
- China
- Prior art keywords
- fructus
- parts
- health
- semen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 60
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title claims abstract description 45
- 208000000689 peptic esophagitis Diseases 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 230000036541 health Effects 0.000 title abstract description 8
- 230000004064 dysfunction Effects 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 32
- 210000000582 semen Anatomy 0.000 claims description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 230000007257 malfunction Effects 0.000 claims description 30
- 241001057584 Myrrha Species 0.000 claims description 25
- 238000011282 treatment Methods 0.000 claims description 25
- 241000244155 Taenia Species 0.000 claims description 22
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 21
- 241000229143 Hippophae Species 0.000 claims description 20
- 235000003935 Hippophae Nutrition 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 18
- 239000008187 granular material Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 8
- 239000000052 vinegar Substances 0.000 claims description 8
- 235000021419 vinegar Nutrition 0.000 claims description 8
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims description 7
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000155 melt Substances 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 240000000950 Hippophae rhamnoides Species 0.000 abstract description 4
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 4
- 240000008042 Zea mays Species 0.000 abstract description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract description 4
- 235000005822 corn Nutrition 0.000 abstract description 4
- 240000007311 Commiphora myrrha Species 0.000 abstract description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract description 2
- 235000017491 Bambusa tulda Nutrition 0.000 abstract description 2
- 240000007049 Juglans regia Species 0.000 abstract description 2
- 235000009496 Juglans regia Nutrition 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 239000011425 bamboo Substances 0.000 abstract description 2
- 235000020234 walnut Nutrition 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000000832 Ayote Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 abstract 1
- 235000009854 Cucurbita moschata Nutrition 0.000 abstract 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 241000508269 Psidium Species 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 235000015136 pumpkin Nutrition 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 23
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 230000006870 function Effects 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 17
- 229940112824 paste Drugs 0.000 description 14
- 210000003238 esophagus Anatomy 0.000 description 13
- 235000013305 food Nutrition 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 10
- 206010025482 malaise Diseases 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 239000004925 Acrylic resin Substances 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 206010067171 Regurgitation Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 210000004877 mucosa Anatomy 0.000 description 6
- 206010019909 Hernia Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 210000001187 pylorus Anatomy 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 241000180579 Arca Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030216 Oesophagitis Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000006881 esophagitis Diseases 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241001339782 Scapharca broughtonii Species 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 241000224239 Tegillarca granosa Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000151 anti-reflux effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- SIXIIKVOZAGHPV-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=C[CH]C2=N1 SIXIIKVOZAGHPV-UHFFFAOYSA-N 0.000 description 2
- 229960003174 lansoprazole Drugs 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- ZHESTCBHMHKZNL-UHFFFAOYSA-N 5,7-dihydroxy-6-methoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=CC(O)=C(OC)C(O)=C3C(=O)C=2)=C1 ZHESTCBHMHKZNL-UHFFFAOYSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000628923 Anadara sativa Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 235000014290 Artemisia anomala Nutrition 0.000 description 1
- 241000123844 Artemisia anomala Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000209128 Bambusa Species 0.000 description 1
- 244000218454 Bambusa tulda Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 101100285402 Danio rerio eng1a gene Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 208000034991 Hiatal Hernia Diseases 0.000 description 1
- 206010020028 Hiatus hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010058522 Oesophageal injury Diseases 0.000 description 1
- 206010030201 Oesophageal ulcer Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000005827 Phyllostachys nigra Species 0.000 description 1
- 235000010717 Phyllostachys nigra Nutrition 0.000 description 1
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000808 adrenergic beta-agonist Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- ZZDWUECZDPGSPL-UHFFFAOYSA-N arteanoflavone Natural products COc1cc(cc(O)c1OC)-c1cc(=O)c2c(OC)c(OC)c(O)cc2o1 ZZDWUECZDPGSPL-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000001126 calcilytic effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 239000000064 cholinergic agonist Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 208000028299 esophageal disease Diseases 0.000 description 1
- 208000019064 esophageal ulcer Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000010271 massa medicata fermentata Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- -1 sulfate radical Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229940052228 zinc oxide paste Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction. The health capsule comprises the following active pharmaceutical ingredients in parts by weight: 5-15 parts of immature bitter orange, 6-12 parts of rhizoma polygoni paleacei, 12-25 parts of corn, 8-16 parts of pumpkin, 6-12 parts of ark shell, 5-15 parts of radish seeds, 3-7 parts of fossilizid, 7-15 parts of sea-buckthorn, 10-20 parts of black sesame, 3-9 parts of walnut kernels, 9-15 parts of diverse wormwood herb, 5-15 parts of largehead atractylodes rhizome, 3-12 parts of myrrh, 3-8 parts of guava and 10-20 parts of bamboo shavings. The health capsule disclosed by the invention has the advantages of scientific formula of traditional Chinese medicine particles and rapid onset of action, and can fundamentally cure reflux esophagitis caused by gastroduodenal dysfunction; and furthermore, the health capsule is simple in preparation method, convenient to take and convenient to carry.
Description
Technical field
The invention discloses a kind of health-caring capsule its preparation method for the treatment of the reflux esophagitis that gastroduodenal malfunction causes, belong to Chinese medicine and field of health care products.
Background technology
Reflux esophagitis (RE) enters by Stomach duodenum content reflux the esophagitis sexually transmitted disease (STD) that esophagus causes to become, and Endoscopic Features is the breakage of Esophageal Mucosa, i.e. rotten to the corn the and (or) esophageal ulcer of esophagus.Reflux esophagitis can betide the crowd at any age, and Adult Onset leads and increases with the age and raise.Hesperian sickness rate is high, and Asia sickness rate is low.This geographic difference may be relevant with h and E factor.But the sickness rate in the recent two decades whole world is all on the rise.Middle-aged and elderly people, obesity, smoking, to drink and stress is greatly the group of people at high risk of reflux esophagitis.
The cause of disease: the 1. destruction of anti-reflux barrier: lower esophageal sphincter (LES) is the higher-pressure region on esophagus and stomach boundary line within the scope of 3 ~ 5cm.This place's rest pressure is 15 ~ 30mmHg, forms a pressure barrier, plays the physiological action preventing gastric content reflux from entering esophagus.Normal person's intra-abdominal pressure increases and causes LES contraction reflection by vagus nerve, and LES is pressed into doubly to be increased in case GER.LES can not cause strong LES contractile response person when pressing through low and intra-abdominal pressure increase, then can cause GER.Cholinergic and beta-adrenergic agonist medicine, alpha-adrenergic antagonistic, dopamine, stable, Calcilytic, morphine and fat, ethanol, caffeine and smoking etc. are multiple all can affect LES function with food factor, brings out GER.In addition, trimester of pregnancy, oral containing Progesterone contraceptive phase and menstrual cycle later stage, blood plasma progesterone levels increases, the incidence rate also corresponding increase of GER.2. esophageal acid cleans up the obstacle of function: normal esophageal acid is cleaned up function and comprised in the emptying and saliva of esophagus and two parts.When acidic gastric contents thing reflux, 1 ~ 2 (10 ~ 15 seconds) secondary esophageal peristalsis is only needed to get final product emptying nearly all reflux thing.Residue in a small amount of acid solution in Esophageal Mucosa lacuna then can by saliva (normal person is per hour 1000 ~ 1500ml, pH be 6 ~ 8 saliva enter stomach through esophagus) neutralization.The function that esophageal acid is cleaned up is that minimizing Esophageal Mucosa is soaked in the time limit in gastric acid, therefore has the effect preventing reflux esophagitis.During nighttime sleep, salivation almost stops, and secondary esophageal peristalsis is also rare generation, and the esophageal acid at night cleans up obvious delay, thus night GER harm even more serious.3. the infringement of Esophageal Mucosa anti-reflux barrier function: when defensive barrier damaged, even if also can cause esophagitis in normal reflux situation.Research finds, the weakening of epitheliosis of esophageal cells and repair ability is one of major reason of reflux esophagitis generation.4. gastroduodenal malfunction: (1) gastric emptying is abnormal.(2) gastroduodenal reflux is when sphincter of pylorus tension force and LES pressure are simultaneously low, hydrochloric acid in gastric juice and pepsin, cholic acid in duodenal juice, pancreatic juice and hemolytic lecithin etc. all reflux can enter esophagus simultaneously, corrode the cuticular layer of esophageal epithelial cell, and make it thinning or come off.H+ in reflux thing and pepsin then go deep into esophageal tissue through the squamous epithelial of new life, cause esophagitis.5. ceasma hernia: commonly sliding hernia.Esophagus and stomach junction surface enters thoracic cavity with body of stomach upward displacement.The rising of body of stomach makes diaphragm foot separately, and ceasma expands.Hernical sac hour, with position, exerts oneself and coughs and slide up and down.Hernical sac no longer slides after increasing, and changes the normal anatomical relationship near ceasma, causes esophagus and stomach junction surface dysraphism.The His angle that the hernia of stomach enters to make esophagus to enter stomach disappears, and diaphragm esophagus film is elongated, thinning, and abdomen section esophagus moves, and the closure function at junction surface is worsened further.Generation reflux esophagitis more than half in the patient of ceasma hernia.6. vomiting during pregnancy: the ceasma hernia occurred because gestation adds intraabdominal pressure can cause reflux esophagitis, but divide a puerperium to recover, need not anyly treat.Vomiting and long-term singultus also can make cardia often open and reflux esophagitis occurs, and can recover normal after removing the cause of disease.7. other diseases: neonate and infant, in growth course, because there being inferior esophageal sphincter dysfunction, reflux occur, with early children development, major part can alleviate.Under primary esophageal, sphincter function is bad makes incompetence, and because organic disease is as distal esophagus and pars cardiaca tumor, scleroderma with variously cause pyloric obstruction etc., all can cause reflux esophagitis.
Therefore, normally the bile of reflux and gastric acid combined effect, in the result of Esophageal Mucosa, and before bile causes esophageal injury, must pre-exist pylorus and LES functional disorder to reflux esophagitis; Reflux esophagitis person is many with gastritis.Sliding hiatal hernia because of often cause LES and pylorus peristaltic function imbalance and easy concurrent primary disease; Duodenal ulcer accompanies by high gastric acid secretion more and easily causes antral spasm and pylorus peristaltic function obstacle, therefore concurrent primary disease is also more.Fat, a large amount of seroperitoneum, latter half of gestation, gastric retention table increase and the factor such as tobacco and wine medicine all can bring out this disease.
Authorization Notice No. is CN 102579389 B(application number 201210072887.6) Chinese patent literature disclose a kind of by name " a kind of pharmaceutical composition ", this pharmaceutical composition comprises lansoprazole and enteric composition, and enteric composition is two kinds in polyacrylic resin I, polyacrylic resin II and polyacrylic resin III; Wherein polyacrylic resin I and polyacrylic resin II weight ratio are 1:10-15; Wherein polyacrylic resin II and polyacrylic resin III weight ratio are 1:11-17; Wherein polyacrylic resin I and polyacrylic resin III weight ratio are 1:5-10; Wherein pharmaceutical composition comprises lansoprazole 15 weight portion, filler 20-50 weight portion, disintegrating agent 10-30 weight portion, alkaline stabiliser 10-30 weight portion, solubilizing agent 5-10 weight portion, lubricant 0.5-1 weight portion.Publication number is CN 1915350A(application number 200510090389) Chinese patent literature disclose a kind of by name " a kind of drug regimen for the treatment of gastropathy ", the Pharmaceutical formulations such as it mainly contains Chinese herbal medicine Rhizoma Atractylodis, the Siberian cocklebur Pericarpium Citri Reticulatae that rues, eastern short, bristly hair or beard, Massa Medicata Fermentata, Fructus Hordei Germinatus, Concha Ostreae, river fore-telling, Fructus Amomi, Aloe, the Rhizoma Atractylodis Macrocephalae, Semen Lablab Album, Cera Flava form.
In a word, Chinese medicine achieves certain effect in treatment gastroduodenal and reflux esophagitis, but also exist fundamentally can not cure, take effect slowly, the deficiency such as toxic and side effects again, need to be improved further, most importantly, current existence be all pure Chinese medicinal preparation, long-term taking is in evil case.
Summary of the invention
For the present situation that prior art is slightly not enough, an object of the present invention is to provide a kind of health-caring capsule for the treatment of the reflux esophagitis that gastroduodenal malfunction causes, health-caring capsule scientific formula of the present invention, instant effect, fundamentally can cure the reflux esophagitis that gastroduodenal malfunction causes, and preparation method is simple, taking convenience, be easy to carry.
Another object of the present invention is to the preparation method of the health-caring capsule of the reflux esophagitis providing above-mentioned treatment gastroduodenal malfunction to cause.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
The health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion: Fructus Aurantii Immaturus 5-15, Rhizoma Polygoni Paleachi 6-12, Semen Maydis 12-25, Fructus Cucurbitae moschatae 8-16, Concha Arcae 6-12, Radix Raphani 5-15, Os Draconis 3-7, Fructus Hippophae 7-15, Semen Sesami Nigrum 10-20, Semen Juglandis 3-9, Herba Artemisiae Anomalae 9-15, Rhizoma Atractylodis Macrocephalae 5-15, Myrrha 3-12, Fructus psidii guajavae immaturus 3-8, Caulis Bambusae In Taenia 10-20.
The health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, preferred scheme, each crude drug is as follows, be weight portion: Fructus Aurantii Immaturus 8-13, Rhizoma Polygoni Paleachi 8-10, Semen Maydis 16-21, Fructus Cucurbitae moschatae 12-14, Concha Arcae 8-10, Radix Raphani 8-13, Os Draconis 4-6, Fructus Hippophae 10-12, Semen Sesami Nigrum 13-18, Semen Juglandis 5-7, Herba Artemisiae Anomalae 11-13, Rhizoma Atractylodis Macrocephalae 8-13, Myrrha 5-10, Fructus psidii guajavae immaturus 4-6, Caulis Bambusae In Taenia 13-18.
The health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, better preferred scheme, each crude drug is as follows, be weight portion: Fructus Aurantii Immaturus 10, Rhizoma Polygoni Paleachi 9, Semen Maydis 18, Fructus Cucurbitae moschatae 13, Concha Arcae 9, Radix Raphani 10, Os Draconis 5, Fructus Hippophae 11, Semen Sesami Nigrum 15, Semen Juglandis 6, Herba Artemisiae Anomalae 12, the Rhizoma Atractylodis Macrocephalae 11, Myrrha 8, Fructus psidii guajavae immaturus 5, Caulis Bambusae In Taenia 15.
The preparation method of the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 80-100 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 10-30 minute (preferably 20 minutes), taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 1-5 minute, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, puts in the hot pot that dryouies and fries 3-8 minute with low baking temperature, take out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 10-30 minute slowly, dries in the air coolly to grind to form smalls, crosses 80-120 mesh sieve (preferably 100 mesh sieves);
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 1-3 time, add Semen Maydis weight 8-12 water doubly, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 4-8 minute, be blended into cold water, turn slow fire boiling 20-40 minute, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste at 50-70 DEG C of dry 10-18 hour, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
The preparation method of above-mentioned health-caring capsule, 1. Os Draconis and Concha Arcae are placed in the hot water (preferably Os Draconis and Concha Arcae being placed in the hot water of 90 DEG C) of 85-95 DEG C by step.
The preparation method of above-mentioned health-caring capsule, step 2. high temperature sterilization 2-4 minute (preferred high temperature sterilization 3 minutes).
The preparation method of above-mentioned health-caring capsule, step 3. little fire is dried 15-25 minute (preferred little fire dries 20 minutes slowly) slowly.
The preparation method of above-mentioned health-caring capsule, 5. step adds Semen Maydis weight 9-11 water (preferably adding the water of Semen Maydis weight 10 times) doubly.
The preparation method of above-mentioned health-caring capsule, step after 5. big fire boils 5-7 minute, is blended into cold water, turns slow fire boiling 25-35 minute (preferred big fire boil 6 minutes after, be blended into cold water, turn slow fire boiling 30 minutes).
The preparation method of above-mentioned health-caring capsule, step 6. thick paste, at 55-65 DEG C of dry 12-16 hour, makes granule (preferred thick paste, 60 DEG C of dryings 14 hours, makes granule).
The present invention is to the Be very effective of anti-fatigue anti-senility, and be the therapeutic effect making the present invention reach best, every day 3 times, taking respectively at half an hour after breakfast, lunch and dinner, each 2, warm water delivery service, 10 days is a course for the treatment of.
The pharmacological effect of each raw material is respectively:
Fructus Aurantii Immaturus: Fructus Aurantii Immaturus, YIN nourishing of enriching blood, moisturizes, hemostasis.For blood deficiency and yellow complexion, dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough.Blood YIN nourishing, moisturizes, hemostasis.For blood deficiency and yellow complexion, dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough.
Rhizoma Polygoni Paleachi: base is former: be the rhizome of Polygonaceae arsesmart Rhizoma Polygoni Paleachi.Composition: Rhizoma Polygoni Paleachi rhizome is containing Combination tannin.The property of medicine: bitter, acrid, cold.Function cures mainly: dissipating blood stasis stops blooding, therapeutic method to keep the adverse QI flowing downwards removing food stagnancy, removing toxic substances, dampness removing.Zhu Zhi WEIJIA is gathered, traumatic injury, traumatic hemorrhage, spits blood, spitting of blood, epistaxis, amenorrhea, metrorrhagia, chronic gastritis, taste-blindness rate, and food stagnation is stagnated, dysentery, enteritis, edema, sore, venom, burn and scald.
Semen Maydis: Semen Maydis is the health-care good product in coarse grain, rather favourable to the health of human body: the compositions such as the vitamin B6 in Semen Maydis, nicotinic acid, there is stimulating gastrointestinal and wriggle, accelerate the characteristic of defecate, can prevent treating constipation, gastropathy, enteritis, intestinal cancer etc.Semen Maydis is rich in vitamin C, dextrinosan etc., has longevity, beautification function.Nutrient substance contained by corn germ point has enhancing human metabolism, adjustment nervous function.Can play and make skin delicacy smooth, suppress, delay wrinkle generation effect.Semen Maydis to have in tune effect of appetizing and blood fat reducing, reduction serum cholesterol.It is relevant with their main edible corn that hypertension is not easily suffered from by Central America American Indian.
Fructus Cucurbitae moschatae: Fructus Cucurbitae moschatae not only has higher edibility, and have very important dietary function.Carry according to " the southern regions of the Yunnan Province book on Chinese herbal medicine ": Fructus Cucurbitae moschatae is warm in nature, and sweet in the mouth is nontoxic, enters spleen, stomach two warp, energy moistening lung qi-benefitting, evacuation of pus of reducing phlegm, anthelmintic is detoxified, and controls and coughs Zhichuan, treats lung abscess constipation, and has the effect such as diuresis, beauty treatment.The bile of Fructus Cucurbitae moschatae secretion can promote enterogastric peristalsis, helps food digestion, and simultaneously pectin wherein can allow people from the stimulation of coarse food, protects our Wei Jiao road mucosa.Fructus Cucurbitae moschatae can make the ability that Liver and kidney function is restored and regenerates in addition, because Fructus Cucurbitae moschatae can eliminate the mutation effect of carcinogen nitrous acid.Also have the composition of a kind of " cobalt " in Fructus Cucurbitae moschatae, after edible, have blood tonification effect.Fructus Cucurbitae moschatae contains abundant vitamin A, b, c and mineral, 8 required seed amino acids and the required histidine of child, the trace element such as soluble fiber, phylloxanthin and phosphorus, potassium, calcium, magnesium, zinc, silicon.Modern age threpsology and medical science show, polyphagia Fructus Cucurbitae moschatae effectively can prevent and treat hypertension, diabetes and hepatic lesions, improve human body immunity.
Concha Arcae: have another name called Carnis Arca inflata shell, watt room, blood clam skin, row of tiles on a roof clam skin, for Carnis Arca inflata section Carnis Arca inflata belongs to the shell that animal Scapharca subcrenata, Scapharca broughtonii and Tegillarca granosa belong to animal Tegillarca granosa.The property of medicine: matter is hard, sweet in the mouth, salty, property is put down.Composition: main component is calcium carbonate, also containing a small amount of calcium phosphate and magnesium, ferrum, silicate.Find according to modern pharmacological research, this medical instrument has effect of expectorant blood stasis dispelling, hard masses softening and resolving, relieving gastric hyperacidity to alleviate stomachache, for pertinacious phlegm chronic cough, and stomachache acid regurgitation, traumatic hemorrhage, gastric and duodenal ulcers.
Radix Raphani: base is former: be fresh of Cruciferae Radix Raphani platymiscium Radix Raphani.Composition: root contains glycoside glucosinolate, glucose raphanin, raphanusin.Phenolic acids: P-coumaric acid, caffeic acid, ferulic acid, phenylpyruvic acid, gentisic acid etc.The property of medicine: acrid, sweet, cool; Ripe person is sweet, flat.Return spleen, stomach, lung, large intestine channel.Function cures mainly: help digestion, and the therapeutic method to keep the adverse QI flowing downwards is reduced phlegm, hemostasis.Cure mainly dyspepsia, food stagnation distension, acid regurgitation, regurgitation of food from the stomach, tells food, and hemorrhoidal hamorrhage is had loose bowels, dysentery, constipation, phlegm-heat cough, discomfort in the throat, hemoptysis, and spit blood, epistaxis, has blood in stool, and quenches one's thirst, and drenches worm.Outer treatment skin ulcer abscess, damage congestive edema, scalds and chilblain.
Os Draconis: base is former: for mammal in ancient times resembles the Skeletal Fossils of class, rhinoceros class, Hippocampal cortex, bovine, deer class etc.Composition: Os Draconis, mainly containing calcium carbonate and calcium phosphate, still contain ferrum, potassium, sodium, chlorine, sulfate radical etc.The property of medicine: puckery, sweet, flat.GUIXIN, liver, kidney, large intestine channel.Function cures mainly: tranquilizing mind, suppressing the hyperactive liver and subsiding YANG, restrains astringent or styptic treatment for spontaneous sweating.Cure mainly cardiopalmus, seized with terror swollen, insomnia, forgetful, infantile convulsion, demented, dizzy, spontaneous sweating, the seminal emission enuresis, bleeding not during menses, chronic diarrhea and dysentery, ulcer does not close up and eczema for a long time.
Fructus Hippophae: base is former: be the fruit of Elaeangnaceae hippophae plant Chinese sea buckthorn and yunnan seabuckthorn.Composition: sea buckthorn fruit is containing pyrite constituents: isorhamnetin, isorhamnetin-3-O--D-Glucose glycosides, rutin, astragalin and Quercetin and kaempferol are the low glucosides etc. of aglycon.The property of medicine: " Chinese herbal medicine is commonly used in Tibet ": " warm in nature, sour in the mouth, puckery." function cures mainly: relieving cough and resolving phlegm, invigorating the stomach and promoting digestion, promoting blood circulation to remove blood stasis.Cure mainly cough with copious phlegm, pulmonary abscess, dyspepsia, abdominal pain due to retention of food, stomachache, enteritis, amenorrhea, traumatic injury congestive edema.
Semen Sesami Nigrum: Semen Sesami Nigrum medicine-food two-purpose, has health-care effecies such as " invigorating the liver and kidney, grow the five internal organs, benefiting essence-blood, intestine moistening is dry ", is regarded as nourishing holy product.Being because containing high quality protein and abundant mineral on the one hand, is because the sesamin containing abundant unsaturated fatty acid, vitamin E and preciousness and melanin on the other hand.
Semen Juglandis: Semen Juglandis is the sarcocarp in walnut kernel, has another name called semen juglandis, Semen Juglandis.1, the strong body of tonify deficiency, provides nutrition: prove through zoopery, containing the mixing-in fat diet of Oleum Juglandis, body weight can be made to increase, and serum albumin increases, and blood cholesterol levels raises comparatively slow, therefore Semen Juglandis is the tonic product of rare a kind of higher fatty acid property material.2, anti-inflammation and sterilization, maintaining skin: Semen Persicae has direct inhibiting bacteria and diminishing inflammation effect.According to clinical report, Semen Juglandis is mashed the Semen Juglandis tar zinc oxide paste made, treatment dermatitis, eczema, effective percentage can reach 100%.The oils and fats that Semen Juglandis is rich in, is conducive to moist skin, keeps human activity.3, cancer-resisting: experiment proves, Semen Juglandis effective ingredient has inhibitory action to mice S37 tumor.Semen Juglandis skill to kinds of tumors, as esophageal carcinoma, gastric cancer, nasopharyngeal carcinoma, pulmonary carcinoma, thyroid carcinoma, lymphosarcoma etc. have certain inhibitory action.In addition, Semen Juglandis also has analgesia to cancer patient, promotes the effect such as leukocyte and the liver protecting.4, brain-strengthening is anti-old: Semen Juglandis contains more protein and the required unsaturated fatty acid of human nutrition, and these compositions are all the important substance of cerebral tissue cellular metabolism, can nursing brain cells, cerebral function improvement.5, purify the blood, reduce cholesterol: Semen Juglandis can reduce the absorption of intestinal to cholesterol.And solubilized cholesterol, " the dirt impurity " got rid of in blood vessel wall makes blood purification, thus provides better fresh blood for human body.So Semen Juglandis prevents arteriosclerosis, reduce the effect of cholesterol.In addition, Semen Juglandis also can be used for treating non-insulin-dependent diabetes mellitus.
Herba Artemisiae Anomalae: have another name called Herba Artemisiae Anomalae grass, Herba Senecionis Scandentis is the wounded in the battle herb of Compositae sagebruss artemisia anomalas.The property of medicine: stem is cylindrical, surperficial brown color or brown-green, matter is hard and crisp, frangibility, the integrated spike panicle of head inflorescence, withered yellow, gas fragrance, bitter in the mouth, pungent, warm in nature.Composition: mainly containing arteanoflavone, tricin, apigenin, Palmic acid etc.Find according to modern pharmacological research, this medical instrument has effect of anti-hypoxia, blood circulation promoting and blood stasis dispelling, removing food stagnancy, hemostasia and detumescence, for amenorrhea due to stagnation of blood, and abdominal pain due to retention of food, hematuria, the diseases such as scald.
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, warm in nature.Return spleen, stomach warp.Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, frequent fetal movement.
Myrrha: Myrrha (Commiphora myrrha Eng1.), has another name called myrrh, other also have the another names such as the raw bright Myrrha of bright Myrrha Myrrha myrrh Myrrha (processed) Myrrha (processed) Myrrha (parched with vinegar) Myrrha.For olive subject plant Herba Violae tree or the dry resin of Ha Didingshu.Main product is in African Somalia, Ethiopia and India and other places.Gather the white oleo-gum-resin of being oozed out by bark crack, in air, become rufous and hard nahlock.After smashing, fry to coke black and apply.Cure mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.There is the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation.Be in the Orient a kind ofly to invigorate blood circulation, blood stasis dispelling, pain relieving, stomach invigorating Chinese medicine.
Fructus psidii guajavae immaturus: be rich in grey matter, ferrum, calcium, phosphorus and various vitamin, has the effects such as treatment diabetes, pre-anti-diarrhea.A large amount of blood sugar lowering prescription being main component with the leaf of Fructus psidii guajavae immaturus and fruit is had in traditional Chinese medical science prescription.Fructus psidii guajavae immaturus is one of autochthonal fruit at last in Taiwan, and belonging to the diet fruit of first-class in Taiwan, is the good diet fruit that market can be seen, also can prophylaxis of hypertension, and obesity, can also toxin expelling facilitating digestion.Can enhance metabolism, regulate physiological function, often guarantor healthy, very suitable patients with diabetes mellitus, and the vitamin C in Fructus psidii guajavae immaturus there is the effect controlling male infertility.Spleen invigorating removing food stagnancy; Relieving diarrhea with astringents.Staple food amasss glutted; Infantile malnutrition; Diarrhoea; Dysentery; Proctoptosis; Metrorrhagia.Astringent therapy antidiarrheal; Pain relieving sore.Main dysentery; Epigastric pain; Toothache; Diabetes; Skin infection; Venom.
Caulis Bambusae In Taenia: Caulis Bambusae In Taenia is traditional Chinese medical science medical material is the dry intermediate layer of stem stalk of grass bambusa breviflora Munro, major part allusion quotation bamboo or phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle.The whole year all can gather and process, and gets fresh stem, and removing crust, spreads to strand by slightly viridant intermediate layer, or chip, tie up bunchy, dry in the shade.The former claims " loose Caulis Bambusae In Taenia ", and the latter claims " neat Caulis Bambusae In Taenia ".Nature and flavor cold nature, sweet in the mouth.Function cures mainly: removing heat-phlegm, relieves restlessness and prevents vomiting.Expectorant, dysphoria with smothery sensation vomiting, palpitation with fear insomnia, middle wind-phlegm fan, aphasia with stiff tongue, gastropyretic vomiting, pregnancy reactions, frequent fetal movement is held under the arm for phlegm-heat cough, gallbladder fire.
The beneficial effect of health-caring capsule of the present invention is, low raw-material cost, any toxic and side effects can not be brought to patient, and it is evident in efficacy, fundamentally can cure the reflux esophagitis that gastroduodenal malfunction causes, the health-caring capsule that the present invention treats the reflux esophagitis that gastroduodenal malfunction causes selects Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Semen Maydis, Fructus Cucurbitae moschatae, Concha Arcae, Radix Raphanis etc. have nourishing the stomach, control abdominal pain, contribute to digestion medicine and carry out compatibility, medicine is made to produce synergism, fundamentally can treat the reflux esophagitis that gastroduodenal malfunction causes.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not by this restriction.
embodiment 1the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion (getting 10g for every part): Fructus Aurantii Immaturus 5, Rhizoma Polygoni Paleachi 6, Semen Maydis 12, Fructus Cucurbitae moschatae 8, Concha Arcae 6, Radix Raphani 5, Os Draconis 3, Fructus Hippophae 7, Semen Sesami Nigrum 10, Semen Juglandis 3, Herba Artemisiae Anomalae 9, the Rhizoma Atractylodis Macrocephalae 5, Myrrha 3, Fructus psidii guajavae immaturus 3, Caulis Bambusae In Taenia 10.
The preparation method of above-mentioned health-caring capsule, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 80 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 10 minutes, taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 1 minute, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, put interior the low baking temperature of hot pot dryouied and fry 3 minutes, taking-up, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 10 minutes slowly, dries in the air coolly to grind to form smalls, crosses 80 mesh sieves;
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 1 time, add the water of Semen Maydis weight 8 times, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 4 minutes, be blended into cold water, turn slow fire boiling 20 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 50 DEG C of dryings 10 hours, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
embodiment 2the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion (getting 20g for every part): Fructus Aurantii Immaturus 15, Rhizoma Polygoni Paleachi 12, Semen Maydis 25, Fructus Cucurbitae moschatae 16, Concha Arcae 12, Radix Raphani 15, Os Draconis 7, Fructus Hippophae 15, Semen Sesami Nigrum 20, Semen Juglandis 9, Herba Artemisiae Anomalae 15, the Rhizoma Atractylodis Macrocephalae 15, Myrrha 12, Fructus psidii guajavae immaturus 8, Caulis Bambusae In Taenia 20.
The preparation method of above-mentioned health-caring capsule, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 100 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 30 minutes, taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 5 minutes, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, put interior the low baking temperature of hot pot dryouied and fry 8 minutes, taking-up, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 30 minutes slowly, dries in the air coolly to grind to form smalls, crosses 120 mesh sieves;
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 3 times, add the water of Semen Maydis weight 12 times, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 8 minutes, be blended into cold water, turn slow fire boiling 40 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 70 DEG C of dryings 18 hours, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
model case one:liu XX, female, 42 years old, Lanxi County, Harbin personage, peasant.Epigastrium distending pain was there is without obvious inducement in patient before March, especially, in 1 hour after the meal, cross and can alleviate gradually, do not draw attention, any Drug therapy is not taken yet, As time goes on, Upper abdominal pain increases the weight of, and occurs burning sample pain, with feeling sick, the discomfort such as acid regurgitation, belch, so remove examination in hospital, be diagnosed as the reflux esophagitis that gastroduodenal malfunction causes on inspection, doctor advised takes embodiment 2 gained health-caring capsule.
Take the present embodiment 2 gained health-caring capsule, take 5 days, patient's malaise symptoms alleviates, acid regurgitation, feel sick etc. disease disappear; Take 10 days, patient's malaise symptoms is clearly better, and partial symptoms disappears; Continue to take 10 days, patient's self-induction is fully recovered, and any discomfort symptom does not appear in period in a medicine.
embodiment 3the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion (getting 30g for every part): Fructus Aurantii Immaturus 8, Rhizoma Polygoni Paleachi 8, Semen Maydis 16, Fructus Cucurbitae moschatae 12, Concha Arcae 8, Radix Raphani 8, Os Draconis 4, Fructus Hippophae 10, Semen Sesami Nigrum 13, Semen Juglandis 5, Herba Artemisiae Anomalae 11, the Rhizoma Atractylodis Macrocephalae 8, Myrrha 5, Fructus psidii guajavae immaturus 4, Caulis Bambusae In Taenia 13.
The preparation method of above-mentioned health-caring capsule, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 85 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 15 minutes, taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 2 minutes, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, put interior the low baking temperature of hot pot dryouied and fry 5 minutes, taking-up, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 10-30 minute slowly, dries in the air coolly to grind to form smalls, crosses 90 mesh sieves;
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 1 time, add the water of Semen Maydis weight 9 times, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 5 minutes, be blended into cold water, turn slow fire boiling 25 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 55 DEG C of dryings 12 hours, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
model case two:cattle XX, man, 40 years old, people from Jiyang County, Jinan City, the leader of certain unit.Dinner party is often gone out in patient's readme at ordinary times, drink a lot, finish off at every turn and all can occur regurgitation, the diseases such as belch, because stomach is not fine always, so diet is also paid much attention to, occur that epigastrium causalgia continues one week recently, regurgitation, the diseases such as belch are also more frequent, take motilium, effect is undesirable, remove examination in hospital, find that patient has chest and diaphragm pain, the discomforts such as flatulence gastric acid, be diagnosed as the reflux esophagitis that gastroduodenal malfunction causes, many medicines have been opened in hospital, go home to take medicine a period of time, symptom is without significant change, be not intended on TV find health-caring capsule of the present invention.
Take the present embodiment 3 gained health-caring capsule, take 7 days, patient's Upper abdominal pain alleviates, and regurgitation, belch number of times obviously reduce; Take 1 day, patient's malaise symptoms disappears substantially, and be clearly better comparatively, continue to take 5 days, patient's malaise symptoms disappears completely, and self-induction is fully recovered, and continues to take and is consolidated for 10 days.
embodiment 4the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion (getting 40g for every part): Fructus Aurantii Immaturus 13, Rhizoma Polygoni Paleachi 10, Semen Maydis 21, Fructus Cucurbitae moschatae 14, Concha Arcae 10, Radix Raphani 13, Os Draconis 6, Fructus Hippophae 12, Semen Sesami Nigrum 18, Semen Juglandis 7, Herba Artemisiae Anomalae 13, the Rhizoma Atractylodis Macrocephalae 13, Myrrha 10, Fructus psidii guajavae immaturus 6, Caulis Bambusae In Taenia 18.
The preparation method of above-mentioned health-caring capsule, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 95 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 25 minutes, taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 4 minutes, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, put interior the low baking temperature of hot pot dryouied and fry 7 minutes, taking-up, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 25 minutes slowly, dries in the air coolly to grind to form smalls, crosses 110 mesh sieves;
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 3 times, add the water of Semen Maydis weight 11 times, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 7 minutes, be blended into cold water, turn slow fire boiling 35 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 65 DEG C of dryings 16 hours, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
embodiment 5the health-caring capsule of the reflux esophagitis that treatment gastroduodenal malfunction causes, each crude drug is as follows, is weight portion (getting 50g for every part): Fructus Aurantii Immaturus 10, Rhizoma Polygoni Paleachi 9, Semen Maydis 18, Fructus Cucurbitae moschatae 13, Concha Arcae 9, Radix Raphani 10, Os Draconis 5, Fructus Hippophae 11, Semen Sesami Nigrum 15, Semen Juglandis 6, Herba Artemisiae Anomalae 12, the Rhizoma Atractylodis Macrocephalae 11, Myrrha 8, Fructus psidii guajavae immaturus 5, Caulis Bambusae In Taenia 15.
The preparation method of above-mentioned health-caring capsule, step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 90 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 20 minutes, taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 3 minutes, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, put interior the low baking temperature of hot pot dryouied and fry 6 minutes, taking-up, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 20 minutes slowly, dries in the air coolly to grind to form smalls, crosses 100 mesh sieves;
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 2 times, add the water of Semen Maydis weight 10 times, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 6 minutes, be blended into cold water, turn slow fire boiling 30 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 60 DEG C of dryings 14 hours, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
experimental exampleembodiment 5 gained health-caring capsule clinical practice: in order to verify the definite curative effect of health-caring capsule of the present invention to the reflux esophagitis that gastroduodenal malfunction causes, clinical selected part patient, as observation contrast object, specifically chooses reference method as follows:
1. little course of disease group: choose that the course of disease is 10-20 days, reflux esophagitis 2 people A and B that pathology and agematched gastroduodenal malfunction cause contrast for a pair, it is 100 right to contrast altogether, and record is on average fully recovered natural law, efficiently individual quantity, invalid number;
2. course of disease group in: choosing the course of disease is that reflux esophagitis 2 people A and B that individual month of 1-2, pathology and agematched gastroduodenal malfunction cause contrasts for a pair, and contrast 100 is right altogether, records natural law of on average fully recovering, efficiently individual quantity, invalid number;
3. severe disease journey group: choosing the course of disease is that reflux esophagitis 2 people A and B that individual month of 3-5, pathology and agematched gastroduodenal malfunction cause contrasts for a pair, and contrast 100 is right altogether, records natural law of on average fully recovering, efficiently individual quantity, invalid number;
In all course of disease groups, the reflux esophagitis medicine (conventional medicine such as motilium, SIDASHU) that A all uses conventional therapy gastroduodenal malfunction to cause, B all uses the embodiment of the present invention 5 gained health-caring capsule.
Criterion, recovery from illness: clinical symptoms disappears completely, and the malaise symptoms such as Upper abdominal pain, beloved wife disappears completely; Effective: clinical symptoms is obviously improved, part malaise symptoms disappears; Invalid: clinical symptoms is unchanged or increase the weight of.Result is as following table 1:
Table 1: embodiment 5 gained health-caring capsule compliance test result
Total efficiently individual quantity=efficiently individual quantity+recovery from illness number
As shown in Table 1, the average curative day of little course of disease group is 7 days, and effective percentage reaches 99%; The average curative day of middle course of disease group is 15 days, and cure rate is 98%; The average curative day of severe disease journey group is 20 days, and effective percentage can reach 97%, and successful is better than A group.Take health-caring capsule therapeutic effect of the present invention significantly and instant effect, effective percentage ensures more than 97%.And recovery from illness patient tracing observation is found, recur after not having a routine drug withdrawal, therefore can prove health-caring capsule of the present invention be a kind of effectively and the Chinese medicine of reflux esophagitis that causes of the treatment gastroduodenal malfunction of safety.
Claims (10)
1. treat the health-caring capsule of the reflux esophagitis that gastroduodenal malfunction causes, it is characterized in that: each crude drug is as follows, is weight portion: Fructus Aurantii Immaturus 5-15, Rhizoma Polygoni Paleachi 6-12, Semen Maydis 12-25, Fructus Cucurbitae moschatae 8-16, Concha Arcae 6-12, Radix Raphani 5-15, Os Draconis 3-7, Fructus Hippophae 7-15, Semen Sesami Nigrum 10-20, Semen Juglandis 3-9, Herba Artemisiae Anomalae 9-15, Rhizoma Atractylodis Macrocephalae 5-15, Myrrha 3-12, Fructus psidii guajavae immaturus 3-8, Caulis Bambusae In Taenia 10-20.
2. the health-caring capsule of reflux esophagitis that causes for the treatment of gastroduodenal malfunction according to claim 1, is characterized in that: each crude drug is as follows, is weight portion: Fructus Aurantii Immaturus 8-13, Rhizoma Polygoni Paleachi 8-10, Semen Maydis 16-21, Fructus Cucurbitae moschatae 12-14, Concha Arcae 8-10, Radix Raphani 8-13, Os Draconis 4-6, Fructus Hippophae 10-12, Semen Sesami Nigrum 13-18, Semen Juglandis 5-7, Herba Artemisiae Anomalae 11-13, Rhizoma Atractylodis Macrocephalae 8-13, Myrrha 5-10, Fructus psidii guajavae immaturus 4-6, Caulis Bambusae In Taenia 13-18.
3. the health-caring capsule of reflux esophagitis that causes for the treatment of gastroduodenal malfunction according to claim 1, is characterized in that: each crude drug is as follows, is weight portion: Fructus Aurantii Immaturus 10, Rhizoma Polygoni Paleachi 9, Semen Maydis 18, Fructus Cucurbitae moschatae 13, Concha Arcae 9, Radix Raphani 10, Os Draconis 5, Fructus Hippophae 11, Semen Sesami Nigrum 15, Semen Juglandis 6, Herba Artemisiae Anomalae 12, the Rhizoma Atractylodis Macrocephalae 11, Myrrha 8, Fructus psidii guajavae immaturus 5, Caulis Bambusae In Taenia 15.
4. the preparation method of the health-caring capsule of the reflux esophagitis that the treatment gastroduodenal malfunction according to any one of claim 1-3 causes, is characterized in that: step is as follows:
1. Os Draconis and Concha Arcae are placed in the hot water of 80-100 DEG C, when water temperature is cooled to room temperature, add Sal, after Sal melts completely, soak 10-30 minute (preferably 20 minutes), taking-up is dried, and is ground into smalls stand-by with pulverizer;
2. get the Rhizoma Atractylodis Macrocephalae and Myrrha to clean, drain away the water, high temperature sterilization 1-5 minute, section, uses rice vinegar uniform spraying, mix after slightly vexed 10 minutes with Semen Sesami Nigrum and Semen Juglandis, puts in the hot pot that dryouies and fries 3-8 minute with low baking temperature, take out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Fructus Aurantii Immaturus, Rhizoma Polygoni Paleachi, Fructus Hippophae, Herba Artemisiae Anomalae and Caulis Bambusae In Taenia, little fire dries 10-30 minute slowly, dries in the air coolly to grind to form smalls, crosses 80-120 mesh sieve (preferably 100 mesh sieves);
4. Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus are cleaned, be cut into coin-size stand-by;
5. Semen Maydis is eluriated 1-3 time, add Semen Maydis weight 8-12 water doubly, soak after 1 hour, big fire adds step 4. gains after boiling, after big fire boils 4-8 minute, be blended into cold water, turn slow fire boiling 20-40 minute, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Fructus Cucurbitae moschatae, Radix Raphani and Fructus psidii guajavae immaturus, add step 1.-3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste at 50-70 DEG C of dry 10-18 hour, make granule, the granule be prepared into is packed according to the preparation technology of capsule and be get final product.
5. the preparation method of health-caring capsule according to claim 4, is characterized in that: 1. Os Draconis and Concha Arcae are placed in the hot water (preferably Os Draconis and Concha Arcae being placed in the hot water of 90 DEG C) of 85-95 DEG C by step.
6. the preparation method of health-caring capsule according to claim 4, is characterized in that: step 2. high temperature sterilization 2-4 minute (preferred high temperature sterilization 3 minutes).
7. the preparation method of health-caring capsule according to claim 4, is characterized in that: step 3. little fire is dried 15-25 minute (preferred little fire dries 20 minutes slowly) slowly.
8. the preparation method of health-caring capsule according to claim 4, is characterized in that: 5. step adds Semen Maydis weight 9-11 water (preferably adding the water of Semen Maydis weight 10 times) doubly.
9. the preparation method of health-caring capsule according to claim 4, is characterized in that: step after 5. big fire boils 5-7 minute, is blended into cold water, turns slow fire boiling 25-35 minute (preferred big fire boil 6 minutes after, be blended into cold water, turn slow fire boiling 30 minutes).
10. the preparation method of health-caring capsule according to claim 4, is characterized in that: step 6. thick paste, at 55-65 DEG C of dry 12-16 hour, makes granule (preferred thick paste, 60 DEG C of dryings 14 hours, makes granule).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410773466.5A CN104474347A (en) | 2014-12-16 | 2014-12-16 | Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410773466.5A CN104474347A (en) | 2014-12-16 | 2014-12-16 | Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104474347A true CN104474347A (en) | 2015-04-01 |
Family
ID=52749048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410773466.5A Pending CN104474347A (en) | 2014-12-16 | 2014-12-16 | Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474347A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1698818A (en) * | 2005-06-09 | 2005-11-23 | 赵东科 | Medicine for treating chronic stomach disease and its preparation method |
CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
CN103182065A (en) * | 2013-03-27 | 2013-07-03 | 朱新华 | Oral liquid for treating gastric and duodenal ulcer efficiently |
CN103404756A (en) * | 2013-05-27 | 2013-11-27 | 胡安然 | Special diet for gastroenteritis patients |
CN103638443A (en) * | 2013-12-30 | 2014-03-19 | 高承香 | Traditional Chinese medicine for treating oesophagitis |
-
2014
- 2014-12-16 CN CN201410773466.5A patent/CN104474347A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1698818A (en) * | 2005-06-09 | 2005-11-23 | 赵东科 | Medicine for treating chronic stomach disease and its preparation method |
CN1919331A (en) * | 2006-08-22 | 2007-02-28 | 夏金陵 | Chinese medicine composition for treating gastritis and preparing method thereof |
CN103182065A (en) * | 2013-03-27 | 2013-07-03 | 朱新华 | Oral liquid for treating gastric and duodenal ulcer efficiently |
CN103404756A (en) * | 2013-05-27 | 2013-11-27 | 胡安然 | Special diet for gastroenteritis patients |
CN103638443A (en) * | 2013-12-30 | 2014-03-19 | 高承香 | Traditional Chinese medicine for treating oesophagitis |
Non-Patent Citations (4)
Title |
---|
李玺等: "沙棘油口服液治疗反流性食管炎100例", 《陕西中医》 * |
白海燕等: "橘皮竹茹汤治疗反流性食道炎", 《四川中医》 * |
石桂珍等: "反流性食管炎的中医药治疗", 《内蒙古中医药》 * |
裴静波: "竹茹枳实汤治疗反流性食管炎36例观察", 《浙江中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110073717A (en) | A functional food and making method of thereof | |
CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
CN104958646A (en) | Chinese medicinal preparation for relaxing bowels and preparation method thereof | |
CN102580048B (en) | Chinese medicine for losing weight and preparation method thereof | |
CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
CN104043095B (en) | Traditional Chinese medicine granules for treating superficial gastritis and reflux esophagitis and preparation method thereof | |
CN104435744A (en) | Traditional Chinese medicine thick paste for treating functional dyspepsia and preparation method of traditional Chinese medicine thick paste | |
CN104971216A (en) | Tea substitute drink for treating constipation and preparation method thereof | |
CN105497677A (en) | Traditional Chinese medicine composition for promoting gastric disease rehabilitation | |
CN103893614A (en) | Traditional Chinese medicine preparation for treating pancreatitis and preparation method thereof | |
CN104474347A (en) | Health capsule for treating reflux esophagitis caused by gastroduodenal dysfunction and preparation method of health capsule | |
CN103638500B (en) | Medicament for treating diaphragmatic spasm and preparation method of medicament | |
CN106620397A (en) | Granules capable of preventing and treating dental ulcer and preparation method of granules | |
CN106237249A (en) | A kind of Chinese medicinal capsule for treating Women’s climacteric insomnia | |
CN105079613A (en) | Nutritive digestion-promoting fresh milk and preparation method thereof | |
CN105194496A (en) | Traditional Chinese medicine composition for mainly treating bone tuberculosis and preparation method | |
CN104857242A (en) | Spleen-invigorating and digestion-promoting preparation for treating infantile malnutrition and preparation method | |
CN104474346A (en) | Health-care capsule for relieving migraine caused by radiation and preparation method thereof | |
CN104784401A (en) | Traditional Chinese medicine preparation for treating stomach cancer | |
CN102940869B (en) | Traditional Chinese medicine composition for treating porcine diarrhea | |
CN104491263A (en) | Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine | |
CN105054114A (en) | Ventilago leiocarpa Benth duck egg for tonifying qi and blood and preparation method thereof | |
CN104606537A (en) | Qi-reinforcing and blood-nourishing medicated diet for improving chemotherapy-induced myocardial ischemic injury and preparation method | |
CN104800687A (en) | Traditional Chinese medicine preparation for treating infantile malnutrition and preparation method thereof | |
CN104814330A (en) | Dog food and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
RJ01 | Rejection of invention patent application after publication |